Company intelligence / Profile preview

MPilotAI

Ownership: Private
Development stage: Other

Overview

MPilotAI has developed an artificial intelligence-driven solution that streamlines and enhances the process of clinical trial protocol design and documentation. The company's platform aims to reduce inefficiencies in clinical research by automating complex tasks, allowing researchers to focus on advancing medical science. No direct information about specific clinical results or therapeutic programs exists as the company operates as a technology enabler for life sciences rather than a drug developer.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on MPilotAI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MPilotAI.

Explore the full profile